Cohort Company News

First AR Spine Surgery Using Augmedics xvision Completed in U.S.

/
DateJun 12 2020
Augmedics’ xvision Spine System has been successfully used for the first time in a spinal fusion surgery in the United States. The system was used in a spinal surgery procedure by Johns Hopkins University surgeons.   Augmedics’ xvision Spine System has been successfully used for the first time in a spinal fusion surgery in the United States. The system was used in a spinal surgery procedure by Johns Hopkins University surgeons. 
Read More →
endotronix logo

Western Ireland’s University Hospital Galway Leading Advanced Heart Failure Monitoring Clinical Trial

/
DateJun 06 2020
The investigational product, known as the Cordella Sensor from U.S.-based company called Endotronix, detects changes in the health of patients with heart failure while securely transmitting information to the cardiovascular team. With this data in real time, the cardiovascular team can not only receive relevant updates but also can intervene with the goal of preventing heart failure flare-up resulting in emergency hospitalization.
Read More →

Rhaeos, Inc. Receives FDA Breakthrough Device Designation for FlowSense™ Noninvasive Thermal Sensor

/
DateJun 01 2020
The Breakthrough Device Designation is supported by data from several recently published studies demonstrating effective use of FlowSense in detecting changes in cerebrospinal fluid volume and flow. By receiving this designation, Rhaeos will work in close collaboration with the FDA to streamline the market clearance process of FlowSense for this high-risk patient population.
Read More →

Arterys Raises $28 Million to Accelerate the Delivery of Medical AI to Practices Around the World

/
DateMay 29 2020
"The current crisis has shown us the necessity of a different approach to providing healthcare, where technology and AI are crucial for future success. Arterys is committed to transforming the way AI is integrated into the medical workflow, a promise that is long due in the industry. We recently launched our cloud platform and marketplace that will consolidate the work of thousands of AI models to be readily available for use by healthcare institutions around the globe," said Henry Weinstein, Managing Partner at Benslie International Ltd.
Read More →
promaxo logo

Medtech Startup Promaxo Raises First Tranche of Series B-1 Funding

/
DateMay 28 2020
Promaxo, an Oakland-based medical technology startup developing the portable single-sided MRI, today announced that it has raised the first tranche of Series B-1 funding. The equity round was led by Kineticos Disruptor Fund with participation from existing investors. Launched in 2016, Promaxo plans to revolutionize healthcare with its MR imaging and robotic platform.
Read More →

Neural Analytics aims robotic transcranial doppler at COVID-19 patients

/
DateMay 28 2020
Doctors are reporting a proliferation of dangerous blood clots in the lungs and other major organs of COVID-19 patients, raising the risk of stroke and other life-threatening complications. While anticoagulant medications can reduce that risk, patients need careful monitoring to ensure their blood is neither too thick nor too thin. To that end, Los Angeles-based startup Neural Analytics Inc. is deploying its robotically assisted transcranial doppler (TCD) system for real-time identification of blood clots and disruptions in blood flow to the brain.
Read More →

FDA greenlights ICU AI for predicting fatal COVID-19 complications

/
DateMay 28 2020
The company’s CLEWICU artificial intelligence software ingests a large range of patient data by linking to electronic medical records, connected medical devices and vital sign monitors, with no need for additional data entry by ICU staff. The FDA also said the standalone CLEWICU software, based within the hospital or in the cloud, could help reduce contact between healthcare workers and COVID-19 patients through remote monitoring.
Read More →
alleviant medical logo

Alleviant Medical completes $6.5m offering

/
DateMay 19 2020
Congestive heart failure treatment developer Alleviant Medical filed an SEC Form D to confirm the sale of $6.5 million in an equity offering. The Austin, Texas-based company reached its total offering amount of $6.5 million after making the first sale in the new notice on May 1. It had no intention of letting the offering last longer than one year and did not make it in connection with a business transaction.
Read More →
1 … 54 55 56 57 58 … 74